Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...
Payer perspective regarding decisions for covering the costs of molecular assays in oncology and reimbursing oncologists for treatments provided to patients while navigating long turnaround times ...
In an ideal world, the oncologist meeting a patient newly diagnosed with nonsmall-cell lung cancer (NSCLC) will already have information on genetic mutations in the tumor, so can initiate targeted ...
Cost-Utility Analysis of Primary Prophylaxis Versus Secondary Prophylaxis With Granulocyte Colony-Stimulating Factor in Elderly Patients With Diffuse Aggressive Lymphoma Receiving Curative-Intent ...
Among the top stories in infectious disease last week were research that found an intervention that included changing the electronic ordering system to encourage urinalysis reflex testing for ...
Lymphocyte Infiltration in Breast Cancer: A Key Prognostic Factor That Should Not Be Ignored This study of mutation testing in patients with NSCLC 25 and other studies that are measuring other genetic ...
The state Department of Health is partnering with Diagnostic Laboratory Services and Clinical Laboratories of Ha-wai’i to encourage providers to do “reflex” hepatitis C testing, in hopes of screening ...
VANCOUVER, British Columbia, July 05, 2023 (GLOBE NEWSWIRE) -- Reflex Advanced Materials Corp. (CSE: RFLX), (OTCQB:RFLXF), (FSE:HF2) (“Reflex” or the “Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback